Leukocyte Activation and Migration in Autoimmune Encephalomyelitis
Leukocyte Activation and Migration in Autoimmune Encephalomyelitis
批准号:
9424637
负责人:
Youhai H Chen
金额:
$40.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-15 至 2021-02-28
关键词:
Antigen ReceptorsAntigensAutoimmune DiseasesBindingBiochemicalBlood - brain barrier anatomyCellsComplexCytoskeletonDefectDevelopmentDiseaseEnvironmental Risk FactorEnzymesExperimental Autoimmune EncephalomyelitisFamilyGene ExpressionGenerationsGenesGeneticGuanosine Triphosphate PhosphohydrolasesHumanHydrophobicityHyperactive behaviorHypersensitivityImmunologicsIn VitroInfiltrationInflammationInflammatoryInjuryIntegrinsKnowledgeLeukocytesLigandsLipidsLocationMalignant NeoplasmsMediatingMembraneModelingMolecularMolecular TargetMultiple SclerosisMusMyelinNeuraxisPDPK1 genePTP4A2 genePathogenicityPathway interactionsPhosphatidylinositolsPhosphoric Monoester HydrolasesPlayProtein FamilyProtein KinaseProteinsProto-Oncogene Proteins c-aktReceptor ActivationReceptor SignalingRegulatory PathwayRegulatory T-LymphocyteResearchResistanceRisk FactorsRoleSecond Messenger SystemsSignal TransductionSiteSpinal CordSystemT cell differentiationT-Cell ActivationT-LymphocyteTCR ActivationTNF geneTestingTissuesWaterbasecell motilitychemokinechemokine receptorclinical practiceexperimental studyextracellularhuman diseaseleukocyte activationmigrationmultiple sclerosis patientnatalizumabphosphatidylinositol 3,4,5-triphosphatepreventprogramspublic health relevancereceptorreceptor bindingrecruittheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall objective of our research program is to understand the molecular mechanisms of leukocyte activation and migration during autoimmune diseases such as multiple sclerosis (MS). A large number of membrane receptors can initiate leukocyte activation and/or migration, which include antigen receptors, chemokine receptors, and integrins. While these receptors bind to a diverse array of extracellular ligands (first messengers), a common intracellular second messenger generated by them is PIP3 (phosphatidylinositol 3,4,5-trisphosphate); PIP3 in turn directs leukocyte activation and migration by binding to dozens of effector proteins (such as protein kinases AKT, BTK, and PDK1) that regulate gene expression and/or cytoskeleton remodeling. This application is inspired by our recent discovery that the genesis and function of the common lipid second messenger PIP3 are controlled by its "professional" transfer proteins of the TNFAIP8 (tumor necrosis factor-α-induced protein 8) family. The TNFAIP8 family possesses a specific hydrophobic cavity that is constitutively occupied by the acyl chains of phosphoinositides such as PIP3, and it is the only known transfer protein family of PIP3. We initially cloned the TIPE2 (TNFAIP8-like 2) gene from spinal cord of mice with experimental autoimmune encephalomyelitis (EAE) and found that it was preferentially expressed by leukocytes. We then generated TIPE2-deficient mice and found that they were significantly resistant to EAE. Unexpectedly, TIPE2-deficient myelin-specific TH1 and TH17 cells were hyper-sensitive to myelin antigens but had an intrinsic defect in migration into CNS. We therefore hypothesize that TNFAIP8 family confers the encephalitogenicity of myelin-specific T cells by controlling the genesis and function of common lipid second messengers that mediate both activation and migration. In its absence, the activation-induced surge of lipid second messengers destroys the internal PIP3 "compass" that guides cell migration, leading to the generation of hyper-active non-encephalitogenic TH1 and TH17 cells not capable of directional migration. This theory will be tested in both murine and human systems (including MS) using genetic, immunological, and biochemical approaches. Specifically, we will determine (I) the mechanism through which TIPE2 and TNFAIP8 regulate myelin-specific T cell activation, and (II) the mechanism through which TIPE2 and TNFAIP8 regulate leukocyte migration during autoimmune encephalomyelitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
-
批准号:9901072
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2019
-
负责人:Youhai H Chen
-
依托单位:
The REL gene and human autoimmune diseases
-
批准号:8989519
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:Youhai H Chen
-
依托单位:
Autoimmune Encephalomyelitis And Regulatory T Cells
-
批准号:9265771
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:Youhai H Chen
-
依托单位:
Autoimmune Encephalomyelitis And Regulatory T Cells
-
批准号:8577267
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2013
-
负责人:Youhai H Chen
-
依托单位:
Type I diabetes and NF-kappa B
-
批准号:8034946
-
项目类别:
-
资助金额:$14.51万
-
财政年份:2010
-
负责人:Youhai H Chen
-
依托单位:
Regulation of Immunity and Inflammation by TIPE2
-
批准号:8240423
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2009
-
负责人:Youhai H Chen
-
依托单位:
Regulation of Immunity and Inflammation by TIPE2
-
批准号:7580297
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2009
-
负责人:Youhai H Chen
-
依托单位:
Regulation of Immunity and Inflammation by TIPE2
-
批准号:7802078
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2009
-
负责人:Youhai H Chen
-
依托单位:
Regulation of Immunity and Inflammation by TIPE2
-
批准号:8049145
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2009
-
负责人:Youhai H Chen
-
依托单位:
Regulation of Immunity and Inflammation by TIPE2
-
批准号:8436250
-
项目类别:
-
资助金额:$36.28万
-
财政年份:2009
-
负责人:Youhai H Chen
-
依托单位:
Transcriptional regulation of Toll-like receptor signaling
-
批准号:7884251
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2008
-
负责人:Youhai H Chen
-
依托单位:
Transcriptional regulation of Toll-like receptor signaling
-
批准号:7505165
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2008
-
负责人:Youhai H Chen
-
依托单位:
Transcriptional regulation of Toll-like receptor signaling
-
批准号:8102769
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2008
-
负责人:Youhai H Chen
-
依托单位:
Transcriptional regulation of Toll-like receptor signaling
-
批准号:7678580
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2008
-
负责人:Youhai H Chen
-
依托单位:
Type I diabetes and NF-kappa B
-
批准号:8033185
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2007
-
负责人:Youhai H Chen
-
依托单位:
Type I diabetes and NF-kappa B
-
批准号:7197684
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2007
-
负责人:Youhai H Chen
-
依托单位:
Type I diabetes and NF-kappa B
-
批准号:7546521
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2007
-
负责人:Youhai H Chen
-
依托单位:
Type I diabetes and NF-kappa B
-
批准号:7334154
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2007
-
负责人:Youhai H Chen
-
依托单位:
Autoimmune encephalomyelitis and Bcl-2- interacting mediator
-
批准号:7342493
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2006
-
负责人:Youhai H Chen
-
依托单位:
Autoimmune encephalomyelitis and Bcl-2- interacting mediator
-
批准号:7558259
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2006
-
负责人:Youhai H Chen
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: